Draft:Schott Pharma

Schott Pharma AG & Co. KGaA
Company type	KGaA with Aktiengesellschaft as partner with unlimited liability
Traded as	FWB: 1SXP
ISIN	DE000A3ENQ51
Industry	Healthcare
Founded	August 1, 2022; 21 months ago
Headquarters	Mainz, Germany
Key people	Andreas Reisse, CEO; Almuth Steinkühler, CFO
Products	Pharmaceutical drug containment and delivery systems
Revenue	€899 million (2022/2023)
Owner	Schott AG
Number of employees	4,646 (as of September 30, 2023)
Divisions	Drug Containment Solutions; Drug Delivery Systems;
Website	schott-pharma.com

Review waiting, please be patient.

This may take 3 months or more, since drafts are reviewed in no specific order. There are 2,548 pending submissions waiting for review.

If the submission is accepted, then this page will be moved into the article space.
If the submission is declined, then the reason will be posted here.
In the meantime, you can continue to improve this submission by editing normally.

Where to get help

If you need help editing or submitting your draft, please ask us a question at the AfC Help Desk or get live help from experienced editors. These venues are only for help with editing and the submission process, not to get reviews.
If you need feedback on your draft, or if the review is taking a lot of time, you can try asking for help on the talk page of a relevant WikiProject. Some WikiProjects are more active than others so a speedy reply is not guaranteed.

How to improve a draft

Wikipedia:Contributing to Wikipedia – a basic overview on how to edit Wikipedia.
Help:Wikitext – how to use the markup
Help:Referencing for beginners – how to include references
Wikipedia:Article development – how to develop your article
Wikipedia:Writing better articles – how to improve your article
Wikipedia:Verifiability – make sure your article includes reliable third-party sources

You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article.

Improving your odds of a speedy review

To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags.

Add tags to your draft

Editor resources

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL
Easy tools: Citation bot (help) | Advanced: Fix bare URLs

Reviewer tools

Instructions · What links here · Schott Pharma (talk: + · bio) · (log) · Copyvios report · reFill · Citation Bot · (Search: Google, Bing, Wikipedia) · Submitted 2 months ago by Elisabeth at SCHOTT (talk: D · +) · Last edited 31 days ago by Elisabeth at SCHOTT

Comment: Please add one or more references to the first paragraph, as far as I think the connection between the creator of this draft and the subject.@Elisabeth at SCHOTT: Hello,firstly, clarify this relation b/w you and this subject?. ~~ αvírαm|(tαlk) 04:42, 6 April 2024 (UTC)

Comment: @Aviram7: Hi, as disclosed on my user page, I am paid for my contributions by Schott AG, which is the parent company of Schott Pharma. I've added the sources to the lead section. Let me know if you have any further questions! Regards, Elisabeth at SCHOTT (talk) 15:10, 8 April 2024 (UTC)

Schott Pharma (stylized as SCHOTT Pharma) is a provider of drug containment solutions and delivery systems for injectable drugs.^[2] Headquartered in Mainz, Germany, the company operates in 14 countries.^[3]

History[edit]

In 1887, Otto Schott developed borosilicate glass for technical applications. Starting in 1911, Schott manufactured borosilicate glass tubing for the production of pharmaceutical ampoules and vials.^[4]

Schott Pharma was established as a standalone company in 2022 through a carve-out from Schott AG, a manufacturer of specialty glass and glass-ceramics.^[5]

In September 2023, Schott Pharma went public on the Frankfurt Stock Exchange. With a value of €935 million, the IPO was the largest of the year in Germany.^[6]^[7] In December 2023, Schott Pharma was included in the SDAX.^[8]

Company Profile[edit]

The company is headquartered in Mainz and operates in 16 locations across 14 countries.^[9]

The company is listed on the Frankfurt Stock Exchange's SDAX. The majority of its shares are held by Schott AG (as of 2023: 77%).^[7]

Schott Pharma develops and manufactures drug containment solutions and delivery systems for injectable drugs, which it supplies to companies in the biotechnology and pharmaceutical industries.^[10]

Its business is divided into two divisions:

Drug Containment Solutions: pharmaceutical vials, cartridges, and glass ampoules
Drug Delivery Systems: prefillable glass syringes and syringes made from Cyclic olefin copolymers (COC), suitable for deep-cold medications.^[11]